"
inequity
lung cancer
social determinants of health
therapeutic trajectory
voice of patients
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2023
2023
Historique:
received:
01
06
2023
accepted:
19
07
2023
medline:
5
9
2023
pubmed:
4
9
2023
entrez:
4
9
2023
Statut:
epublish
Résumé
Globally, it has been reported that different social determinants of health affect health outcomes in lung cancer (LC). Research on the therapeutic trajectories of patients (TTP) is a novel field for identifying barriers and facilitators in health. The objective of this study was to reveal perceived differences in TTP with LC in Chile according to selected social determinants of health (SDH) and the experiences of patients, health professionals, and civil society leaders. This is a qualitative paradigm, one case-study design. Online semi-structured interviews were conducted with patients with LC, health professionals, and civil society leaders. The strategies for the recruitment process included social networks, civil society organizations, health professionals, and the snowball technique. A thematic analysis was carried out. Selected SDH impact LC's TTP in Chile, particularly concerning health system access, health services, information, and patient navigation experiences. The analysis of the experiences of the participants allowed us to identify barriers related to the selected SDH in three stages of the TTP: initiation, examinations, and diagnosis and treatment. Individuals with limited education, those residing outside the capital, women, and those in the public health system encountered more barriers throughout their TTP. Study findings suggest that being a woman with low education, from the public health system, and not from the capital might represent one of the most powerful intersections for experiencing barriers to effective healthcare in LC in Chile. It is necessary to monitor the TTP from an SDH perspective to guarantee the rights of access, opportunity, quality, and financial protection.
Sections du résumé
Background
Globally, it has been reported that different social determinants of health affect health outcomes in lung cancer (LC). Research on the therapeutic trajectories of patients (TTP) is a novel field for identifying barriers and facilitators in health. The objective of this study was to reveal perceived differences in TTP with LC in Chile according to selected social determinants of health (SDH) and the experiences of patients, health professionals, and civil society leaders.
Methods
This is a qualitative paradigm, one case-study design. Online semi-structured interviews were conducted with patients with LC, health professionals, and civil society leaders. The strategies for the recruitment process included social networks, civil society organizations, health professionals, and the snowball technique. A thematic analysis was carried out.
Results
Selected SDH impact LC's TTP in Chile, particularly concerning health system access, health services, information, and patient navigation experiences. The analysis of the experiences of the participants allowed us to identify barriers related to the selected SDH in three stages of the TTP: initiation, examinations, and diagnosis and treatment. Individuals with limited education, those residing outside the capital, women, and those in the public health system encountered more barriers throughout their TTP.
Discussion
Study findings suggest that being a woman with low education, from the public health system, and not from the capital might represent one of the most powerful intersections for experiencing barriers to effective healthcare in LC in Chile. It is necessary to monitor the TTP from an SDH perspective to guarantee the rights of access, opportunity, quality, and financial protection.
Identifiants
pubmed: 37663832
doi: 10.3389/fpubh.2023.1228304
pmc: PMC10468573
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1228304Informations de copyright
Copyright © 2023 Campaña, Cabieses, Obach and Vezzani.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
PLoS One. 2022 Mar 18;17(3):e0265321
pubmed: 35303029
Rev Panam Salud Publica. 2015 Jan;37(1):44-51
pubmed: 25791187
BMC Fam Pract. 2021 Jan 7;22(1):10
pubmed: 33413135
Acta Oncol. 2017 Feb;56(2):123-127
pubmed: 28033027
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Acta Oncol. 2002;41(2):147-52
pubmed: 12102158
PLoS One. 2020 Sep 24;15(9):e0239445
pubmed: 32971530
Dimens Crit Care Nurs. 2017 Jul/Aug;36(4):253-263
pubmed: 28570380
Cancer. 2015 Nov 15;121(22):4016-24
pubmed: 26385420
Asia Pac J Clin Oncol. 2018 Feb;14(1):5-15
pubmed: 28929586
Health Inf Sci Syst. 2017 Apr 12;5(1):1
pubmed: 28413630
J Adv Nurs. 2008 Feb;61(3):336-43
pubmed: 18197868
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29
pubmed: 24399786
Cancer. 2015 Nov 15;121(22):4025-34
pubmed: 26348120
Rev Gaucha Enferm. 2020 Jun 05;41:e20190166
pubmed: 32520113
Lancet. 2019 Jun 15;393(10189):2440-2454
pubmed: 31155275
BMC Cancer. 2018 Oct 4;18(1):951
pubmed: 30286733
Public Health. 2020 Aug;185:189-195
pubmed: 32645506
BMC Prim Care. 2022 May 18;23(1):119
pubmed: 35585504
Int J Health Policy Manag. 2019 Sep 01;8(9):550-556
pubmed: 31657177
Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1614-7
pubmed: 23045534
Stud Health Technol Inform. 2007;129(Pt 2):910-4
pubmed: 17911848
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Support Care Cancer. 2022 Dec 14;31(1):21
pubmed: 36513843
Front Pediatr. 2015 Aug 03;3:67
pubmed: 26284228
J Rural Health. 2012 Jan;28(1):54-62
pubmed: 22236315
Cancer. 2008 Dec 15;113(12):3391-9
pubmed: 18951521
Adv Exp Med Biol. 2016;893:1-19
pubmed: 26667336
Health Policy Plan. 2014 Sep;29(6):717-31
pubmed: 23921988
Soc Sci Med. 2009 Apr;68(8):1448-55
pubmed: 19233532
Soc Sci Med. 2006 Mar;62(6):1381-91
pubmed: 16168544
PLoS One. 2021 Sep 22;16(9):e0257680
pubmed: 34550996
Oncologist. 2015 Dec;20(12):1378-85
pubmed: 26512045
Soc Sci Med. 2013 Jul;89:16-24
pubmed: 23726211
Am J Public Health. 2012 Jul;102(7):1267-73
pubmed: 22594719
J Community Genet. 2019 Jan;10(1):35-39
pubmed: 29781042
J Patient Exp. 2023 Jan 17;10:23743735231151533
pubmed: 36698621
Cad Saude Publica. 2015 Sep;31(9):1975-82
pubmed: 26578021